News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Amgen (AMGN)'s First Quarter 2014 Revenues Increased 7 Percent To $4.5 Billion


4/23/2014 6:41:22 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

THOUSAND OAKS, Calif., April 22, 2014 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced financial results for the first quarter of 2014. Key results include:

•Total revenues increased 7 percent to $4,521 million, with 5 percent product sales growth driven by Kyprolis® (carfilzomib), XGEVA® (denosumab), Prolia® (denosumab) and Neulasta® (pegfilgrastim).

Help employers find you! Check out all the jobs and post your resume.

Read at PR Newswire

comments powered by Disqus
Amgen
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES